SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-124683
Filing Date
2021-04-21
Accepted
2021-04-21 16:07:51
Documents
4
Period of Report
2021-04-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d161452d8k.htm 8-K 25258
2 EX-10.1 d161452dex101.htm EX-10.1 49224
3 EX-99.1 d161452dex991.htm EX-99.1 10838
4 GRAPHIC g161452cerevel_logo.jpg GRAPHIC 4889
  Complete submission text file 0001193125-21-124683.txt   93608
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39311 | Film No.: 21841591
SIC: 2834 Pharmaceutical Preparations